Emerald Development Managers

Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

WATT Fuel Cell Corporation is a developer and manufacturer of solid oxide fuel cell (SOFC) systems and components, based in Mount Pleasant, Pennsylvania. Founded in 2010, the company specializes in creating fuel cells that operate on readily available hydrocarbon fuels, including natural gas, propane, JP-8, and diesel. WATT's technology is designed to provide efficient, clean, and environmentally responsible energy solutions for various sectors, including marine and recreational vehicles, emergency response, military, and remote power applications. The company offers a hybrid SOFC system that integrates hydrocarbon fuels with renewable energy sources like solar and wind, optimizing power output and energy storage. Its modular design allows for scalable solutions, enabling clients to increase power capacity by adding additional modules as needed, similar to a blade server configuration.

Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

WATT Fuel Cell Corporation is a developer and manufacturer of solid oxide fuel cell (SOFC) systems and components, based in Mount Pleasant, Pennsylvania. Founded in 2010, the company specializes in creating fuel cells that operate on readily available hydrocarbon fuels, including natural gas, propane, JP-8, and diesel. WATT's technology is designed to provide efficient, clean, and environmentally responsible energy solutions for various sectors, including marine and recreational vehicles, emergency response, military, and remote power applications. The company offers a hybrid SOFC system that integrates hydrocarbon fuels with renewable energy sources like solar and wind, optimizing power output and energy storage. Its modular design allows for scalable solutions, enabling clients to increase power capacity by adding additional modules as needed, similar to a blade server configuration.

Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.